Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (171)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (13)
Alopecia (7)
Anti-inflammatory (8)
Antidepressants (9)
Ascorbic Acid (9)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (8)
COVID-19 (255)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (10)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (6)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (46)
long COVID (21)
Mast Cells (8)
Melatonin (20)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
resveratrol (5)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (15)
spermidine (11)
Spike Protein (10)
Thrombosis (9)
Tinnitus (12)
Valproic Acid (5)
Vitamin C (16)
Vitamin D (9)
Zinc (12)
More than 1.6 million Americans have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more than 10 times that number carry antibodies to it.
Categories:
Reference: Combined pirfenidone, azithromycin and prednisolone in post-H1N1 ARDS pulmonary firbosis.
Authors: Saba A, Vaidya PJ, Chavhan VB, Achlerkar A, Leuppi J PMID: 32476885 PMCID: PMC7170064 DOI: 10.36141/svdld.v35i1.6393 Abstract There are no specific data on the management of pulmonary fibrosis post-H1N1 ARDS. We present the cases of three patients who responded positively to treatment with pirfenidone, azithromycin and prednisolone. Three males, aged 40, 45 and 59 [...]
Categories: I-RECOVER Long Covid
Tags: azithromycin, pirfenidone, Prednisone
